| Literature DB >> 32048207 |
Renata Orłowska1, Piotr Tomasz Bednarek2.
Abstract
KEY MESSAGE: The Taguchi method and metAFLP analysis were used to optimise barley regenerants towards maximum and minimum levels of tissue culture-induced variation. The subtle effects of symmetric and asymmetric methylation changes in regenerants were identified. Plant tissue cultures (PTCs) provide researchers with unique materials that accelerate the development of new breeding cultivars and facilitate studies on off-type regenerants. The emerging variability of regenerants derived from PTCs may have both genetic and epigenetic origins, and may be desirable or degrade the value of regenerated plants. Thus, it is crucial to determine how the PTC variation level can be controlled. The easiest way to manipulate total tissue culture-induced variation (TTCIV) is to utilise appropriate stress factors and suitable medium components. This study describes the optimisation of in vitro tissue culture-induced variation in plant regenerants derived from barley anther culture, and maximizes and minimizes regenerant variation compared with the source explants. The approach relied on methylation amplified fragment length polymorphism (metAFLP)-derived TTCIV characteristics, which were evaluated in regenerants derived under distinct tissue culture conditions and analysed via Taguchi statistics. The factors that may trigger TTCIV included CuSO4, AgNO3 and the total time spent on the induction medium. The donor plants prepared for regeneration purposes had 5.75% and 2.01% polymorphic metAFLP loci with methylation and sequence changes, respectively. The level of TTCIV (as the sum of all metAFLP characteristics analyzed) identified in optimisation and verification experiments reached 7.51 and 10.46%, respectively. In the trial designed to produce a minimum number of differences between donor and regenerant plants, CuSO4 and AgNO3 were more crucial than time, which was not a significant factor. In the trial designed to produce a maximum number of differences between donor and regenerant plants, all factors had comparable impact on variation. The Taguchi method reduced the time required for experimental trials compared with a grid method and suggested that medium modifications were required to control regenerant variation. Finally, the effects of symmetric and asymmetric methylation changes on regenerants were identified using novel aspects of the metAFLP method developed for this analysis.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32048207 PMCID: PMC7170832 DOI: 10.1007/s11103-020-00973-5
Source DB: PubMed Journal: Plant Mol Biol ISSN: 0167-4412 Impact factor: 4.076
Induction tests for in vitro plant regeneration of barley via androgenesis (anther cultures)
| Trial | Factors | ||
|---|---|---|---|
| CuSO4 (µM) | AgNO3 (µM) | Length of induction (days) | |
| M1 | 0.1 | 0 | 21 |
| M2 | 0.1 | 10 | 28 |
| M3 | 0.1 | 60 | 35 |
| M4 | 5 | 60 | 28 |
| M5 | 5 | 0 | 35 |
| M6 | 5 | 10 | 21 |
| M7 | 10 | 10 | 35 |
| M8 | 10 | 60 | 21 |
| M9 | 10 | 0 | 28 |
M1—control conditions, M2–M9—variations for testing the Taguchi method
Optimised induction trials for in vitro plant regeneration of barley via androgenesis (anther cultures)
| Trial | Optimised factors | ||
|---|---|---|---|
| CuSO4 (µM) | AgNO3 (µM) | Length of induction (days) | |
| M10 | 0.1 | 0 | 21 |
| M12 | 10 | 60 | 21 |
| M13 | 2.95 | 15 | 28 |
M10—control, M12 and M13—the lowest and highest percentage of differences, respectively, between donor and regenerant plants based on total tissue culture-induced variation (TTCIV)
Formulae for quantification of demethylation variation (DMV), de novo methylation variation (DNMV) and sequence variation (SV) within the CXX, CG and CXG methylation context
| Code | Formula |
|---|---|
| Z_E | Z_0000 + Z_0001 + Z_0010 + Z_0011 + Z_0100 + Z_0101 + Z_0110 + Z_0111 + Z_1000 + Z_1001 + Z_1010 + Z_1011 + Z_1100 + Z_1101 + Z_1110 + Z_1111 |
| Z_SE | Z_0001 + Z_0010 + Z_0101 + Z_0110 + Z_1001 + Z_1010 + Z_1101 + Z_1110 |
| Z_DME | Z_0110 + Z_0111 |
| Z_DNME | Z_1001 + Z_1011 |
| Z_CE | Z_0100 + Z_1000 |
| Z_SNMSs | Z_1100 + Z_1101 + Z_1111 |
| Z_SMSs | Z_0011 + Z_1101 |
| Z_TTCIE | Z_SE + Z_DME + Z_DNME + Z_CE |
| CXX_D1 ('0000') | CXX_SE + CXX_DME + CXX_DNME + CXX_CE + CXX_SNMSs + CXX_SMSs + CXX_'0000' |
| CG_D1 ('0000') | CG_SE + CG_DME + CG_DNME + CG_CE + CG_SNMSs + CG_SMSs + CG_'0000' |
| CXG_D1 ('0000') | CXG_SE + CXG_DME + CXG_DNME + CXG_CE + CXG_SNMSs + CXG_SMSs + CXG_'0000' |
| D1 ('0000') | CXX_D1 ('0000') + CG_D1 ('0000') + CXG_D1 ('0000') |
| Z_DMV | 100 × Z_DME/D1 ('0000') |
| Z_DNMV | 100 × Z_DNME/D1 ('0000') |
| Z_SV | 100 × Z_SE/D1 ('0000') |
| Z_CV | 100 × Z_CE/D1 ('0000') |
| Z_TTCIV | 100 × Z_TTCIE/D1 ('0000') |
| Z_SV_CN | Z_SV + [Z_SV × Z_CV/(Z_SV + Z_DMV + Z_DNMV)]/Z_E |
| Z_DMV_CN | Z_DMV + [Z_DMV × Z_CV/(Z_SV + Z_DMV + Z_DNMV)]/Z_E |
| Z_DNMV_CN | Z_DNMV + [Z_DNMV × Z_CV/(Z_SV + Z_DMV + Z_DNMV)]/Z_E |
| Z_dMET_CN | Z_DNMV_CN-Z_DMV_CN |
| Methylation context | 3′-ends of selective primers |
| CXX | AAA, AAT, ATA, ATT, TAA, TAT, TTA, etc |
| CG | CGG, CGA, CGT, CGC, GCG, GCA, GCT, GCC, etc. |
| CXG | AAG, AAC, ATG, ATC, TAG, TAC, TTG, etc. |
D1 (‘0000’) states for the denominator 1; _C—correction for complex variation, Z—methylation context or without context depending on the marker set used for quantification, E—number of ‘events’
Fig. 1Agglomeration analysis (UPGMA) based on Jaccard similarity coefficients of Acc65I/MseI–KpnI/MseI (M) AFLPs identifies site DNA methylation changes in anther-derived regenerants of Experiment 1. Regenerants from the M1–M9 trials and the donor plant (JDHII) are included. Bootstrap values are indicated at the nodes
Fig. 2Agglomeration analysis (UPGMA) based on Jaccard similarity coefficients of KpnI/MseI (K) AFLPs identifies DNA sequence changes in anther-derived regenerants of Experiment 1. Regenerants derived in the M1–M9 trials and the donor plant (JDHIIK) are included. Bootstrap values are indicated at the nodes
ANOVA statistics for each of the metAFLP characteristics and arrangement of the average metAFLP characteristics evaluated for the M1–M9 trials. Z represents all sequence contexts taken together
| metAFLP characteristic | ||||||
|---|---|---|---|---|---|---|
| Z_TTCIV | Z_SV_CN | Z_DMV_CN | Z_DNMV_CN | Z_dMET_CN | ||
| ANOVA | F | 49.434 | 119.666 | 24.368 | 0.773 | 23.380 |
| 0.0001 | 0.0001 | 0.0001 | 0.629 | 0.0001 | ||
| Trials | M1 | 6.53b | 2.96b | 1.48a | 0.74a | − 0.74b |
| M2 | 6.20b | 2.36b | 1,48a | 0.74a | − 0.74 b | |
| M3 | 7.03b | 3.42b | 1.48a | 0.69a | − 0.79b | |
| M4 | 5.86b | 2.32b | 1.39a | 0.70a | − 0.70b | |
| M5 | 6.85b | 3.15b | 1.53a | 0.74a | − 0.79b | |
| M6 | 5.74b | 2.50b | 1.11a | 0.70a | − 0.42b | |
| M7 | 6.62b | 3.15b | 1.53a | 0.74a | − 0.79b | |
| M8 | 15.43a | 13.03a | 0.00b | 0.79a | 0.79a | |
| M9 | 7.32b | 3.20b | 1.53a | 0.70a | − 0.84b | |
M1—control, M2–M9—optimisation trials. The Z_TTCIV, Z_SV_CN, Z_DMV_CN, Z_DNMV_CN and Z_dMET_CN characteristics reflect total tissue culture-induced variation, sequence variation, demethylation, de novo methylation and change in DNA methylation, respectively. The a, b and c superscript letters indicate Tukey’s grouping. The presented data do not include outliers that were excluded based on Grubs test
Fig. 3Agglomeration analysis (UPGMA, Jaccard) of metAFLPs related to DNA methylation change (Acc65I/MseI–KpnI/MseI, M) for the M10–M13 trials. The M10 trial mirrors control conditions. The M12 and M13 regenerants were derived according to the optimised conditions for minimum and maximum differences between donor and regenerant plants, respectively. Bootstrap value is indicated on the nodes
Fig. 4Agglomeration analysis (UPGMA, Jaccard) of metAFLPs related to the DNA mutations (KpnI/MseI) (K) for the M10–M13 trials. The M10 trial mirrors control conditions. The M12 and M13 regenerants were derived according to the optimised conditions for minimum and maximum differences between donor and regenerant plants, respectively. Bootstrap value is indicated on the nodes
ANOVA statistics for each of the metAFLP characteristics in the verification process and averaged metAFLP characteristics evaluated for the M10, M12 and M13 trials
| metAFLP characteristic | ||||||
|---|---|---|---|---|---|---|
| Z_TTCIV | Z_SV_CN | Z_DMV_CN | Z_DNMV_CN | Z_dMET_CN | ||
| ANOVA | F | 2.400 | 0.759 | 1.009 | 0.639 | 0.671 |
| 0.123 | 0.484 | 0.387 | 0.541 | 0.525 | ||
| Trial | M10 | 11.37a | 4.30a | 1.77a | 2.92a | 0.69a |
| M12 | 9.69a | 3.84a | 1.50a | 2.45a | 0.40a | |
| M13 | 10.31a | 4.06a | 1.24a | 2.78a | 0.61a | |
M10—control; M12 and M13—verification trials. Z_TTCIV, Z_SV_CN, Z_DMV_CN, Z_DNMV_CN and Z_dMET_CN reflect total tissue culture-induced variation, sequence variation, demethylation, de novo methylation and change in DNA methylation, respectively. The a, b and c superscript letters indicate Tukey’s grouping. Z represents all sequence contexts taken together
ANOVA and Tukey’s grouping of methylation contexts within DMV and DNMV as well as grouping of differences between Z_DMV_CN and Z_DMV_CN within CG, CXG and CXX methylation contexts when trials were not distinguished
| metAFLP characteristic (%) | Methylation context | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Z_DMV_CN | Z_DNMV_CN | Z_dMET_CN | CG | CXG | CXX | |||||
| ANOVA | F | 71.239 | 108.7470 | 6.615 | ANOVA | F | 17.789 | 28.512 | 0.004 | |
| 0.0001 | 0.0001 | 0.003 | 0.000 | 0.0001 | 0.951 | |||||
| Methylation context | CG | 1.19a | 1.88a | 0.68a | metAFLP characteristic(%) | Z_DMV_CN | 1.19b | 0.18b | 0.08a | |
| CXG | 0.18b | 0.73b | 0.55a | |||||||
| CXX | 0.08b | 0.08c | 0.00b | Z_DNMV_CN | 1.88a | 0.73a | 0.08a | |||
Superscript letters indicate Tukey’s grouping.
ANOVA and Tukey’s grouping of the M10–M13 trials by methylation context in Z_DNMV_CN and Z_DMV_CN
| Methylation context | CG | CXG | CXX | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| metAFLP characteristic | Z_DMV_CN | Z_DNMV_CN | Z_dMET_CN | Z_DMV_CN | Z_DNMV_CN | Z_dMET_CN | Z_DMV_CN | Z_DNMV_CN | Z_dMET_CN | |
| ANOVA | F | 2.274 | 0.401 | 1.146 | 0.930 | 1.637 | 0.671 | 7.719 | 5.057 | 4.023 |
| p | 0.135 | 0.677 | 0.343 | 0.415 | 0.225 | 0.525 | 0.005 | 0.020 | 0.038 | |
| Trial | M10 | 1.47a | 1.69a | 0.22a | 0.31a | 1.00a | 0.69a | 0.00b | 0.23a | 0.23a |
| M12 | 1.33a | 1.87a | 0.54a | 0.17a | 0.58a | 0.40a | 0.00b | 0.00b | 0.00b | |
| M13 | 0.94a | 1.98a | 1.04a | 0.11a | 0.72a | 0.61a | 0.19a | 0.08ab | − 0.11ab | |
| ANOVA | F | 0.201 | 0.288 | 0.281 | 0.580 | 5.259 | 1.194 | – | 17.168 | 17.168 |
| p | 0.664 | 0.604 | 0.609 | 0.466 | 0.048 | 0.503 | – | 0.003 | 0.003 | |
| Trial | M10 | 1.47a | 1.69a | 0.22a | 0.31a | 1.00a | 0.69a | – | 0.23a | 0.23a |
| M12 | 1.33a | 1.87a | 0.54a | 0.17a | 0.58b | 0.40a | – | 0.00b | 0.00b | |
| ANOVA | F | 2.463 | 0.792 | 1.621 | 6.055 | 1.087 | 0.096 | 5.555 | 2.921 | 5.027 |
| p | 0.148 | 0.394 | 0.232 | 0.034 | 0.322 | 0.763 | 0.040 | 0.118 | 0.049 | |
| Trial | M10 | 1.47a | 1.69a | 0.22a | 0.31a | 1.00a | 0.69a | 0.00b | 0.23a | 0.23a |
| M13 | 0.94a | 1.98a | 1.04a | 0.11b | 0.72a | 0.61a | 0.19a | 0.08a | -0.11b | |
| ANOVA | F | 5.867 | 0.162 | 1.431 | 0.210 | 0.569 | 0.778 | 10.110 | 2.022 | 1.063 |
| p | 0.031 | 0.694 | 0.253 | 0.655 | 0.464 | 0.394 | 0.007 | 0.179 | 0.321 | |
| Trial | M12 | 1.33a | 1.87a | 0.54a | 0.17a | 0.58a | 0.40a | 0.00b | 0.00a | 0.00a |
| M13 | 0.94b | 1.98a | 1.04a | 0.11a | 0.72a | 0.61a | 0.19a | 0.08b | − 0.11a | |
Superscript letters reflect Tukey’s grouping.
Pearson correlation for sequence changes (Z_SV_CN) and difference in methylation (Z_dMET_CN), demethylation (Z_DMV_CN), and de novo methylation (Z_CN) in symmetric and asymmetric methylation contexts in all trials and in individual trials
| Trials | Methylation context | CG | CXG | CXX | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| metAFLP characteristics | Z_SV_CN-Z_dMET_CN | Z_SV_CN-Z_DMV_CN | Z_SV_CN-Z_DNMV_CN | Z_SV_CN-Z_dMET_CN | Z_SV_CN-Z_DMV_CN | Z_SV_CN-Z_DNMV_CN | Z_SV_CN-Z_dMET_CN | Z_SV_CN-Z_DMV_CN | Z_SV_CN-Z_DNMV_CN | |
| All trials | Correlation matrix | 0.000 | 0.017 | 0.017 | 0.269 | 0.037 | 0.323 | − 0.205 | 0.022 | 0.311 |
| 0.999 | 0.944 | 0.945 | 0.265 | 0.881 | 0.177 | 0.399 | 0.929 | 0.195 | ||
| M10 | Correlation matrix | − 0.963 | 0.989 | − 0.900 | 0.530 | − 0.099 | 0.526 | − 0.956 | – | − 0.956 |
| 0.037 | 0.011 | 0.100 | 0.470 | 0.901 | 0.474 | 0.044 | 0 | 0.044 | ||
| M12 | Correlation matrix | − 0.066 | 0.157 | − 0.025 | 0.285 | − 0.142 | 0.330 | – | – | – |
| 0.887 | 0.736 | 0.958 | 0.536 | 0.761 | 0.470 | 0 | 0 | 0 | ||
| M13 | Correlation matrix | 0.625 | − 0.694 | 0.553 | 0.522 | 0.583 | 0.728 | –0.818 | 0.714 | − 0.818 |
| 0.098 | 0.056 | 0.156 | 0.184 | 0.129 | 0.041 | 0.013 | 0.047 | 0.013 | ||